KCNE3 Protein

KCNE3 Protein (MinK-Related Peptide 3)

Overview

KCNE3 (also known as MinK-related peptide 3 or MiRP2) is a potassium channel regulatory subunit that modulates the function of voltage-gated potassium channels, particularly [KCNQ1](/proteins/kcnq1-protein) (also known as Kv7.1). The protein plays critical roles in regulating neuronal excitability, cardiac repolarization, and epithelial transport. KCNE3 is encoded by the [KCNE3](/genes/kcne3) gene located on chromosome 11.

KCNE3 is a member of the KCNE family (KCNE1-5), which are small single-pass membrane proteins that assemble with voltage-gated potassium channel α-subunits to form functional channels with diverse properties. Unlike KCNE1, which slows activation, KCNE3 accelerates activation and shifts the voltage dependence of channel opening.

Structure

KCNE3 Protein (MinK-Related Peptide 3)

Overview

KCNE3 (also known as MinK-related peptide 3 or MiRP2) is a potassium channel regulatory subunit that modulates the function of voltage-gated potassium channels, particularly [KCNQ1](/proteins/kcnq1-protein) (also known as Kv7.1). The protein plays critical roles in regulating neuronal excitability, cardiac repolarization, and epithelial transport. KCNE3 is encoded by the [KCNE3](/genes/kcne3) gene located on chromosome 11.

KCNE3 is a member of the KCNE family (KCNE1-5), which are small single-pass membrane proteins that assemble with voltage-gated potassium channel α-subunits to form functional channels with diverse properties. Unlike KCNE1, which slows activation, KCNE3 accelerates activation and shifts the voltage dependence of channel opening.

Structure

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">KCNE3 Protein</th></tr>
<tr><td><strong>Protein Name</strong></td><td>KCNE3 (MinK-Related Peptide 3)</td></tr>
<tr><td><strong>Gene</strong></td><td>[KCNE3](/genes/kcne3)</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q9NP86](https://www.uniprot.org/uniprot/Q9NP86)</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>17.6 kDa</td></tr>
<tr><td><strong>Subcellular Location</strong></td><td>Plasma membrane</td></tr>
<tr><td><strong>Protein Family</strong></td><td>KCNE family (MinK-related peptides)</td></tr>
<tr><td><strong>Gene Location</strong></td><td>11q13.4</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">8 edges</a></td>
</tr>
</table>
</div>

Molecular Architecture

KCNE3 contains a single transmembrane α-helix that anchors the protein in the plasma membrane. The extracellular N-terminal domain and intracellular C-terminal tail interact with the S4-S5 linker and C-terminal domain of KCNQ1 channels to modulate their gating properties. The protein forms disulfide bonds with channel β-subunits and undergoes post-translational modifications including glycosylation.

Normal Physiological Function

Potassium Channel Modulation

KCNE3 primarily assembles with [KCNQ1](/proteins/kcnq1-protein) to form channels with distinct properties compared to KCNE1-containing channels. Key functions include:

• KCNQ1/KCNE3 channels: Generate slowly activating, non-inactivating currents that contribute to the M-current, a key regulator of neuronal excitability
• Voltage dependence: Shifts activation to more negative potentials, making channels more responsive at resting membrane potentials
• Kinetic properties: Accelerates activation kinetics compared to homomeric KCNQ1 channels

Tissue Distribution

KCNE3 is expressed in:

• Brain: Hippocampus, cortex, and basal ganglia — regions affected in Alzheimer's and Parkinson's disease
• Heart: Cardiac ventricles where it contributes to repolarization
• Inner ear: Hair cells involved in auditory transduction
• Epithelial tissues: Kidney and intestine

Neuronal Function

In neurons, KCNQ1/KCNE3 channels regulate:

• Resting membrane potential stability
• Action potential threshold
• Spike frequency adaptation
• Synaptic integration

Role in Neurodegenerative Diseases

Alzheimer's Disease

Potassium channel dysfunction is increasingly recognized in Alzheimer's disease pathophysiology:

• Aβ toxicity: Amyloid-β peptides directly affect KCNQ1 channel function, disrupting neuronal excitability
• Calcium dysregulation: KCNE3-containing channels may contribute to calcium homeostasis through voltage control
• Network hyperexcitability: Loss of M-current function leads to cortical hyperexcitability observed in AD patients
• Therapeutic potential: SK channel activators (related potassium channels) are under investigation for AD treatment [@potassium2004]

Parkinson's Disease

Evidence for KCNE3 involvement in PD:

• Dopaminergic neuron survival: Potassium channels regulate dopaminergic neuron excitability and survival
• Motor control: KCNQ1/KCNE3 channels in the striatum modulate movement
• Mitochondrial function: Channel dysfunction may contribute to energy metabolism deficits
• Potential therapeutic target: Modulating neuronal excitability is a PD therapeutic strategy [@potassium2010]

Amyotrophic Lateral Sclerosis (ALS)

• Motor neuron excitability: Potassium channels regulate motor neuron excitability; dysfunction may contribute to ALS pathogenesis
• Channel modulators under investigation: Research into potassium channel openers for ALS therapy continues

Therapeutic Implications

KCNE3 and related potassium channels represent potential therapeutic targets:

Genetic Associations

KCNE3 mutations are associated with:

• Cardiac arrhythmias: Brugada syndrome and atrial fibrillation
• Sudden infant death syndrome: Channel dysfunction in cardiac tissue
• Gitelman syndrome: When combined with other channel mutations

Therapeutic Targeting

Current Research Status

• Preclinical stage: KCNE3-specific modulators are not yet in clinical trials
• Related targets: SK channels (KCNN1-4) are further along in development for neurodegenerative diseases
• Challenge: Developing subtype-selective KCNE modulators due to high similarity among KCNE proteins

Drug Development Opportunities

• Natural compounds: Certain plant-derived compounds modulate KCNQ channels
• Repurposing potential: Existing potassium channel activators could be investigated for neurodegenerative applications

Cross-Links

• [KCNE3 Gene](/genes/kcne3)
• [KCNQ1 Protein](/proteins/kcnq1-protein)
• [Potassium Channels in Neurodegeneration](/mechanisms/potassium-channel-dysfunction)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Neuronal Excitability](/mechanisms/neuronal-excitability)

References

See Also

• [Potassium Channel Dysfunction](/mechanisms/potassium-channel-dysfunction)
• [Ion Channel Therapeutics](/mechanisms/ion-channel-therapeutics)
• [Neuronal Excitability in Neurodegeneration](/mechanisms/neuronal-excitability)
• [Alzheimer's Disease Mechanisms](/mechanisms/alzheimers-disease-mechanisms)
• [Parkinson's Disease Mechanisms](/mechanisms/parkinsons-disease-mechanisms)